Effect of nicotine use and withdrawal on preproenkephalin a mRNA

Brain Research

Volumn 799, Issue 2, 1998, Pages 257-263

  Houdi, A A ^a,c   Dasgupta, R ^a   Kindy, M S ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c University of Kentucky   (United States)

Author keywords

Hippocampus; Mecamylamine; Nicotine chronic; Nicotine withdrawal; Striatum

Indexed keywords

MECAMYLAMINE; MESSENGER RNA; NICOTINE; PREPROENKEPHALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; HIPPOCAMPUS; MALE; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; RNA ANALYSIS; SMOKING;

ANIMALS; BLOTTING, NORTHERN; BRAIN; ENKEPHALINS; GENE EXPRESSION; MALE; NICOTINE; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME; TISSUE DISTRIBUTION;

EID: 0032551579     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00454-5     Document Type: Article

References (47)

1. J.A. Angulo, B.S. McEwen, Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens, Brain Res. Rev. 19 (1994) 1-28.
2. C. Auffray, F. Rougeon, Purification of mouse immunoglobulin heavy chain mRNAs from total myeloma tumor RNA, Eur. J. Biochem. 107 (1980) 303-312.
3. J.A. Baron, Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious, Br. Med. Bull. 52 (1996) 58-73.
4. E. Bostock, M. Gallagher, R.A. King, Effects of opioid microinjections into the medial septal area on spatial memory in rats, Behav. Neurosci. 102 (1988) 643-652.
5. N. Breslau, M.M. Kilbey, P. Andreski, Nicotine dependence and major depression, Arch. Gen. Psychiatry 50 (1993) 31-35.
6. K.A. Campbell, N.W. Milgram, J.K. Christoff, Plasticity in the reinforcing consequences of hippocampal stimulation, Brain Res. 159 (1978) 458-462.
7. V. Clement-Jones, P.J. Lowry, L.H. Rees, G.M. Besser, Met-enkephalin circulates in human plasma, Nature 283 (1980) 295-297.
8. T.J. Collier, A. Routhenberg, Electrical self-stimulation of dentate gyrus granule cells, Behav. Neural Biol. 42 (1984) 85-90.
9. W.A. Corrigall, K.M. Coen, Selective dopamine antagonists reduce nicotine self-administration, Psychopharmacology 104 (1991) 171-176.
10. W.A. Corrigall, K.B.J. Franklin, K.M. Coen, P.B.S. Clarke, The mesolimbic dopamine system is implicated in the reinforcing effects of nicotine, Psychopharmacology 107 (1992) 285-289.
11. E. Costa, P. Panula, H.K. Thompson, D.L. Cheney, The transsynaptic regulation of the septal-hippocampal cholinergic neurons, Life Sci. 32 (1983) 165-179.
12. M.D.C. de Felipe, I. Jimenez, A. Castro, J.A. Fuentes, Antidepressant action of imipramine and iptindole in mice is enhanced by inhibitors of enkephalin-degrading peptidases, Eur. J. Pharmacol. 159 (1989) 175-180.
13. R.K. Dhatt, K.P. Gudehithlu, T.A. Wemlinger, G.A. Tejwani, N.H. Neff, M. Hadjiconstantinou, Preproenkephalin mRNA and Methionine-enkephalin content are increased in mouse striatum after treatment with nicotine, J. Neurochem. 64 (1995) 1878-1883.
14. J.H. Fallen, F.M. Leslie, Distribution of dynorphin and enkephalin peptides in the rat brain, J. Comp. Neurol. 249 (1986) 293-336.
15. A. Fienberg, B. Vogelstein, A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity, Anal. Biochem. 132 (1982) 6-9.
16. M. Gallagher, Behavioral significance of opioid peptides in relation to hippocampal function, in: J.F. McGinty, D.P. Friedman (Eds.), Opioids in the Hippocampus. NIDA Res. Monograph No. 82, 1988, pp. 118-132.
17. R. Galared, J. Gallart, J.M. Arguello, S. Schwartz, J.M. Castellanos, R. Catalan, Plasma levels of β-endorphin, cortisol, prolactin and growth hormone in depressed patients, Acta Psychiatr. Scand. 78 (1988) 230-233.
18. M. Gallagher, M.W. Meagher, E. Bostock, Effects of opiate manipulations on latent inhibition in rabbits: sensitivity of the medial septal region to intracranial treatments, J. Neurosci. 101 (1987) 315-324.
19. E.L. Gardner, R.S. Zukin, M.H. Makman, Modulation of opiate receptor binding in striatum and amygdala by selective mesencephalic lesions, Brain Res. 194 (1980) 232-239.
20. S.R. George, M. Kertesz, Met-enkephalin concentrations in striatum respond reciprocally to alterations in dopamine neurotransmission, Peptides 8 (1987) 487-492.
21. A.H. Glassman, J.E. Heizer, L.S. Covey, L.B. Cottier, F. Stetner, F.J.E. Tipp, J. Johnson, Smoking, smoking cessation, and major depression, J. Am. Med. Assoc. 264 (1990) 1546-1549.
22. M.S. Gold, A.C. Pottash, D. Sweeney, D. Martin, I. Extein, I. Antimanic, antidepressant, and antipanic effects of opiates: clinical, neuroanatomical, and biochemical evidence, Ann. New York Sci. 398 (1982) 140-150.
23. J. Gross, M.L. Stitzer, Nicotine replacement: ten-week effects on tobacco withdrawal symptoms, Psychopharmacology 98 (1989) 334-341.
24. J.E. Henningfield, L.M. Schuh, M.E. Jarvik, in: F.W. Bloom, D.J. Kupfer (Eds.), Psychopharmacology, the Fourth Generation of Progress, Raven Press, 1995, pp. 1715-1729.
25. A.A. Houdi, G.R. Van Loon, Haloperidol-induced increase in striatal concentration of the tripeptide, Tyr-Gly-Gly, provides an index on increased enkephalin release in vivo, J. Neurochem. 54 (1991) 1360-1366.
26. A.A. Houdi, K. Pierzchala, L. Marson, M. Palkovits, G.R. Van Loon, Nicotine-induced alteration in Tyr-Gly-Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity, Peptides 12 (1991) 161-166.
27. J.R. Hughes, Tobacco withdrawal in self-quitters, J. Consult. Clin. Psychol. 60 (1992) 689-697.
28. J.R. Hughes, D.K. Hatsukama, J.E. Mitchell, L.A. Dahigren, Prevalence of smoking among psychiatric outpatients, Am. J. Psychiatry 143 (1986) 993-997.
29. A. Imperato, A. Mulas, G. Di Chiara, Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats, Eur. J. Pharmacol. 132 (1986) 337-338.
30. J.H. Jaffe, M. Kanzler, Smoking as an addictive disorder, in: N.A. Krassnegor (Ed.), Cigarette Smoking as a Dependence Process. Natl. Inst. Drug Abuse (NIDA) Res. Monogr. Ser. No. 23, 1979, pp. 4-23.
31. C. Llorens-Cortes, J.-C. Schwartz, Changes in turnover of cerebral monoamines following inhibition of enkephalin metabolism by thiorphan and bestatin, Eur. J. Pharmacol. 104 (1984) 369-374.
32. S.R. McGurk, E.D. Levin, L.L. Butcher, Nicotinic-dopaminergic relationships and radial-arm maze performance in rats, Behav. Neural Biol. 52 (1989) 78-86.
33. S. Mclean, R.B. Rothman, A.E. Jacobson, K.C. Rice, M.J. Herkenham, Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamster, J. Comp. Neurol. 255 (1987) 497-510.
34. J.-C. Mifsud, L. Hernandez, B.G. Hoebel, Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis, Brain Res. 478 (1989) 365-367.
35. D.M. Morens, A. Grandinett, D. Reed, L.R. White, G.W. Ross, Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?, Neurology 45 (1995) 1041-1051.
36. 2 antagonists, Neuroscience 25 (1988) 525-532.
37. M. Nisell, G.G. Nomikos, T.H. Svensoon, Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area, Synapse 16 (1994) 36-44.
38. K. Pierzchala, A.A. Houdi, G.R. Van Loon, Nicotine induced alteration in brain regional concentration of cryptic Met- and Leu-enkephalin, Peptides 8 (1987) 1035-1043.
39. S. Pögün, E. Koylu, S. Demirgören, E.D. London, Gender difference in neuronal nicotine receptors and the effects of chronic nicotine administration and nicotine withdrawal in rats, Soc. Neurosci. B 21 (1995) 11.
40. F.E. Pontieri, G. Tanda, F. Orzi, G. Di Chiara, Effects of nicotine on the nucleus accumbens and similarity to those od addictive drugs, Nature 382 (1996) 255-257.
41. S.P. Sivam, C. Strunk, D.R. Smith, J.S. Hong, Proenkephalin A gene regulation in the rat striatum: influence of lithium and haloperidol, Mol. Pharmacol. 30 (1986) 186-191.
42. K.E. Stevens, G. Shiotsu, L. Stein, Hippocampal μ-receptors mediate opioid reinforcement in the CA3 region, Brain Res. 545 (1991) 8-16.
43. P. Stolerman, M.J. Jarvis, The scientific case that nicotine is addictive, Psychopharmacology 117 (1995) 2-10.
44. F. Tang, E. Costa, J.P. Schwartz, Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks, Proc. Natl. Acad. Sci. USA 80 (1983) 3841-3844.
45. T.J. Teyler, P. DeScenna, The role of hippocampus in memory: a hypothesis, Neurosci. Biobehav. Rev. 9 (1985) 377-389.
46. C.M. van Duijn, A. Hofman, Relation between nicotine intake and Alzheimer's disease, BMJ 302 (1991) 1491-1492.
47. P.L. Wood, Phasic enkephalinergic modulation of nigrostriatal dopamine metabolism: potentiation with enkephalinase inhibitors, Eur. J. Pharmacol. 82 (1982) 119-120.